Cell cycle regulation by the intrinsically disordered proteins p21 and p27

Biochemical Society Transactions

Volumn 40, Issue 5, 2012, Pages 981-988

  Yoon, Mi Kyung ^a   Mitrea, Diana M ^a   Ou, Li ^a   Kriwacki, Richard W ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

Cell cycle regulator; Intrinsically disordered proteins; p21; p27; Tyrosine phosphorylation

Indexed keywords

CYCLIN DEPENDENT KINASE; INTRINSICALLY DISORDERED PROTEIN; PROTEIN; PROTEIN P21; PROTEIN P27; PROTEIN P53; RHO KINASE; THREONINE; TYROSINE; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; CARBOXY TERMINAL SEQUENCE; CARCINOGENESIS; CELL CYCLE G1 PHASE; CELL CYCLE REGULATION; CELL CYCLE S PHASE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN FOLDING; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN SECONDARY STRUCTURE; PROTEIN STRUCTURE; REVIEW; SIGNAL TRANSDUCTION;

CELL CYCLE; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLIN-DEPENDENT KINASE INHIBITOR P27; HUMANS; MODELS, MOLECULAR;

EID: 84866689134     PISSN: 03005127     EISSN: 14708752     Source Type: Journal    
DOI: 10.1042/BST20120092     Document Type: Review

References (56)

1. Wright, P.E. and Dyson, H.J. (1999) Intrinsically unstructured proteins: re-assessing the protein structure-function paradigm. J. Mol. Biol. 293, 321-331
2. Chouard, T. (2011) Structural biology: breaking the protein rules. Nature 471, 151-153
3. Funk, J.O. and Galloway, D.A. (1998) Inhibiting CDK inhibitors: new lessons from DNA tumor viruses. Trends Biochem. Sci. 23, 337-341
4. Iakoucheva, L.M., Brown, C.J., Lawson, J.D., Obradovic, Z. and Dunker, A.K. (2002) Intrinsic disorder in cell-signaling and cancer-associated proteins. J. Mol. Biol. 323, 573-584
5. Wang, Y., Fisher, J.C., Mathew, R., Ou, L., Otieno, S., Sublet, J., Xiao, L., Chen, J., Roussel, M.F. and Kriwacki, R.W. (2011) Intrinsic disorder mediates the diverse regulatory functions of the Cdk inhibitor p21. Nat. Chem. Biol. 7, 214-221
6. Iakoucheva, L.M., Radivojac, P., Brown, C.J., O'Connor, T.R., Sikes, J.G., Obradovic, Z. and Dunker, A.K. (2004) The importance of intrinsic disorder for protein phosphorylation. Nucleic Acids Res. 32, 1037-1049
7. Gnad, F., Gunawardena, J. and Mann, M. (2011) PHOSIDA 2011: the posttranslational modification database. Nucleic Acids Res. 39, D253-D260
8. Kip1 are directly regulated by oncogenic tyrosine kinases. Cell 128, 269-280
9. Hyeon, C. and Onuchic, J.N. (2007) Mechanical control of the directional stepping dynamics of the kinesin motor. Proc. Natl. Acad. Sci. U.S.A. 104, 17382-17387
10. Morgan, J.L., Song, Y. and Barbar, E. (2011) Structural dynamics and multi-region interactions in dynein-dynactin recognition. J. Biol. Chem. 286, 39349-39359
11. Yamada, J., Phillips, J.L., Patel, S., Goldfien, G., Calestagne-Morelli, A., Huang, H., Reza, R., Acheson, J., Krishnan, V.V., Newsam, S. et al. (2010) A bimodal distribution of two distinct categories of intrinsically disordered structures with separate functions in FG nucleoporins. Mol. Cell. Proteomics 9, 2205-2224
12. Noutsou, M., Duarte, A.M., Anvarian, Z., Didenko, T., Minde, D.P., Kuper, I., de Ridder, I., Oikonomou, C., Friedler, A., Boelens, R. et al. (2011) Critical scaffolding regions of the tumor suppressor Axin1 are natively unfolded. J. Mol. Biol. 405, 773-786
13. Dyson, H.J. and Wright, P.E. (2005) Intrinsically unstructured proteins and their functions. Nat. Rev. Mol. Cell Biol. 6, 197-208
14. Mark, W.Y., Liao, J.C., Lu, Y., Ayed, A., Laister, R., Szymczyna, B., Chakrabartty, A. and Arrowsmith, C.H. (2005) Characterization of segments from the central region of BRCA1: an intrinsically disordered scaffold for multiple protein-protein and protein-DNA interactions? J. Mol. Biol. 345, 275-287
15. Davey, N.E., Trave, G. and Gibson, T.J. (2011) How viruses hijack cell regulation. Trends Biochem. Sci. 36, 159-169
16. Sickmeier, M., Hamilton, J.A., LeGall, T., Vacic, V., Cortese, M.S., Tantos, A., Szabo, B., Tompa, P., Chen, J., Uversky, V.N. et al. (2007) DisProt: the Database of Disordered Proteins. Nucleic Acids Res. 35, D786-D793
17. waf1/cip1/sdi1 in the free and Cdk2-bound state: conformational disorder mediates binding diversity. Proc. Natl. Acad. Sci. U.S.A. 93, 11504-11509
18. Kip1 exhibits intrinsic structure resembling the Cdk2/cyclin A-bound conformation. J. Mol. Biol. 353, 1118-1128
19. Bienkiewicz, E.A., Adkins, J.N. and Lumb, K.J. (2002) Functional consequences of preorganized helical structure in the intrinsically disordered cell-cycle inhibitor p27Kip1. Biochemistry 41, 752-759
20. Kip1 cyclin-dependent-kinase inhibitor bound to the cyclin A-Cdk2 complex. Nature 382, 325-331
21. Oldfield, C.J., Meng, J., Yang, J.Y., Yang, M.Q., Uversky, V.N. and Dunker, A.K. (2008) Flexible nets: disorder and induced fit in the associations of p53 and 14-3-3 with their partners. BMC Genomics 9 (Suppl. 1), S1
22. 1cyclin-dependent kinases. Cell 75, 805-816
23. 1cyclin-Cdk protein kinase activity, is related to p21. Cell 78, 67-74
24. Kip1 CDK 'inhibitors' are essential activators of cyclin D-dependent kinases in murine fibroblasts. EMBO J. 18, 1571-1583
25. Cip1 promotes cyclin D1 nuclear accumulation via direct inhibition of nuclear export. J. Biol. Chem. 277, 8517-8523
26. LaBaer, J., Garrett, M.D., Stevenson, L.F., Slingerland, J.M., Sandhu, C., Chou, H.S., Fattaey, A. and Harlow, E. (1997) New functional activities for the p21 family of Cdk inhibitors. Genes Dev. 11, 847-862
27. Blain, S.W. (2008) Switching cyclin D-Cdk4 kinase activity on and off. Cell Cycle 7, 892-898
28. Zhang, H., Hannon, G.J. and Beach, D. (1994) p21-containing cyclin kinases exist in both active and inactive states. Genes Dev. 8, 1750-1758
29. Kip1. ACS Chem. Biol. 7, 678-682
30. Waf1/Cip1. Oncogene 18, 5381-5392
31. cip1/waf1/sdi1 in DNA replication and transcription. J. Biol. Chem. 275, 10477-10483
32. WAF1/CIP1/SDI1. J. Biol. Chem. 275, 18794-18800
33. Kip1 modulates cell migration through the regulation of RhoA activation. Genes Dev. 18, 862-876
34. 1 arrest. Nat. Med. 8, 1153-1160
35. Kip1phosphorylation at T198 to promote RhoA inhibition and increase cell motility. Proc. Natl. Acad. Sci. U.S.A. 106, 9268-9273
36. Cip1/WAF1 by Akt-induced phosphorylation in Her-2/neu-overexpressing cells. Nat. Cell Biol. 3, 245-252
37. Cip1/WAF1 regulates neurite remodeling by inhibiting Rho-kinase activity. J. Cell Biol. 158, 321-329
38. Waga, S., Hannon, G.J., Beach, D. and Stillman, B. (1994) The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA. Nature 369, 574-578
39. Funk, J.O., Waga, S., Harry, J.B., Espling, E., Stillman, B. and Galloway, D.A. (1997) Inhibition of CDK activity and PCNA-dependent DNA replication by p21 is blocked by interaction with the HPV-16 E7 oncoprotein. Genes Dev. 11, 2090-2100
40. Ghanem, L. and Steinman, R. (2005) A proapoptotic function of p21 in differentiating granulocytes. Leuk. Res. 29, 1315-1323
41. WAF1/Cip1: more than a break to the cell cycle? Biochim. Biophys. Acta 1471, M43-M56
42. Abbas, T. and Dutta, A. (2009) p21 in cancer: intricate networks and multiple activities. Nat. Rev. Cancer 9, 400-414
43. Besson, A., Dowdy, S.F. and Roberts, J.M. (2008) CDK inhibitors: cell cycle regulators and beyond. Dev. Cell 14, 159-169
44. kip1 C-terminal scatter domain mediates Rac-dependent cell migration independent of cell cycle arrest functions. Mol. Cell. Biol. 23, 216-228
45. Lacy, E.R., Filippov, I., Lewis, W.S., Otieno, S., Xiao, L., Weiss, S., Hengst, L. and Kriwacki, R.W. (2004) p27 binds cyclin-CDK complexes through a sequential mechanism involving binding-induced protein folding. Nat. Struct. Mol. Biol. 11, 358-364
46. Lacy, E.R., Wang, Y., Post, J., Nourse, A., Webb, W., Mapelli, M., Musacchio, A., Siuzdak, G. and Kriwacki, R.W. (2005) Molecular basis for the specificity of p27 toward cyclin-dependent kinases that regulate cell division. J. Mol. Biol. 349, 764-773
47. Shoemaker, B.A., Portman, J.J. and Wolynes, P.G. (2000) Speeding molecular recognition by using the folding funnel: the fly-casting mechanism. Proc. Natl. Acad. Sci. U.S.A. 97, 8868-8873
48. Day, P.J., Cleasby, A., Tickle, I.J., O'Reilly, M., Coyle, J.E., Holding, F.P., McMenamin, R.L., Yon, J., Chopra, R., Lengauer, C. and Jhoti, H. (2009) Crystal structure of human CDK4 in complex with a D-type cyclin. Proc. Natl. Acad. Sci. U.S.A. 106, 4166-4170
49. Takaki, T., Echalier, A., Brown, N.R., Hunt, T., Endicott, J.A. and Noble, M.E. (2009) The structure of CDK4/cyclin D3 has implications for models of CDK activation. Proc. Natl. Acad. Sci. U.S.A. 106, 4171-4176
50. Vlach, J., Hennecke, S. and Amati, B. (1997) Phosphorylation-dependent degradation of the cyclin-dependent kinase inhibitor p27. EMBO J. 16, 5334-5344
51. Zhu, H., Nie, L. and Maki, C.G. (2005) Cdk2-dependent inhibition of p21 stability via a C-terminal cyclin-binding motif. J. Biol. Chem. 280, 29282-29288
52. Cip1 in S phase. J. Biol. Chem. 278, 25752-25757
53. Galea, C.A., Nourse, A., Wang, Y., Sivakolundu, S.G., Heller, W.T. and Kriwacki, R.W. (2008) Role of intrinsic flexibility in signal transduction mediated by the cell cycle regulator, p27 Kip1. J. Mol. Biol. 376, 827-838
54. Waf1/Cip1/Sdi1 and its implications for molecular recognition. Protein Sci. 18, 337-347
55. Waf1/Cip1 as a therapeutic target in breast and other cancers. Cancer Cell 4, 425-429
56. Collins, I. and Garrett, M.D. (2005) Targeting the cell division cycle in cancer: CDK and cell cycle checkpoint kinase inhibitors. Curr. Opin. Pharmacol. 5, 366-373